BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2019 11:50:46 AM | Browse: 787 | Download: 1510
 |
Received |
|
2019-04-28 03:02 |
|
Peer-Review Started |
|
2019-05-07 01:09 |
|
To Make the First Decision |
|
2019-06-03 03:17 |
|
Return for Revision |
|
2019-06-12 01:57 |
|
Revised |
|
2019-06-19 14:21 |
|
Second Decision |
|
2019-07-02 10:31 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-07-03 16:47 |
|
Articles in Press |
|
2019-07-03 16:47 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-07-18 14:09 |
|
Typeset the Manuscript |
|
2019-07-31 07:00 |
|
Publish the Manuscript Online |
|
2019-08-06 11:50 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Obstetrics & Gynecology |
| Manuscript Type |
Observational Study |
| Article Title |
Clinical significance and function of up-regulation of SERPINA3 expression in endometrial cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mian-Li Zhou, Fang-Shan Chen and Hui Mao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hui Mao, MD, Professor, Department of Oncology, Traditional Chinese Medicine Hospital Affiliated to Southwest Medical University, No. 182 Chunhui Road, Longmatan District, Luzhou 646000, Sichuan Province, China. 15196087724@163.com |
| Key Words |
Serpin peptidase inhibitor, clade A member 3; Endometrial cancer; Quantitative polymerase chain reaction; Expression; ; |
| Core Tip |
Serpin peptidase inhibitor, clade A member 3 (SERPINA3) is considered to be associated with several cancers. In this study, the clinical significance and role of SERPINA3 expression in endometrial cancer was investigated. It was found that the expression of SERPINA3 was up-regulated in endometrial cancer and expression of SERPINA3 in endometrial cancer is correlated with pathological grade, clinical stage, vascular invasion and lymph node metastasis. SERPINA3 has the potential to be used as a biomarker for prognosis and a specific target for targeted therapy in patients with endometrial carcinoma. |
| Publish Date |
2019-08-06 11:50 |
| Citation |
Zhou ML, Chen FS, Mao H. Clinical significance and function of up-regulation of SERPINA3 expression in endometrial cancer. World J Clin Cases 2019; 7(15):1996-2002 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i15/1996.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i15.1996 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
